C07C 335/04
Derivatives of thiourea
C07C335/04 (Derivatives of thiourea) appears on 602 US grants and 441 published applications in this corpus.
Search patents in C07C- Granted patents
- 602
- Published applications
- 441
- Assignees
- 346
- Inventors
- 1,737
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 23 | 0 |
| 1978 | 16 | 0 |
| 1979 | 5 | 0 |
| 1980 | 5 | 0 |
| 1981 | 6 | 0 |
| 1982 | 13 | 0 |
| 1983 | 5 | 0 |
| 1984 | 10 | 0 |
| 1985 | 10 | 0 |
| 1986 | 9 | 0 |
| 1987 | 5 | 0 |
| 1988 | 11 | 0 |
| 1989 | 10 | 0 |
| 1990 | 11 | 0 |
| 1991 | 13 | 0 |
| 1992 | 13 | 0 |
| 1993 | 9 | 0 |
| 1994 | 7 | 0 |
| 1995 | 17 | 0 |
| 1996 | 11 | 0 |
| 1997 | 22 | 0 |
| 1998 | 13 | 0 |
| 1999 | 7 | 0 |
| 2000 | 15 | 0 |
| 2001 | 19 | 3 |
| 2002 | 20 | 23 |
| 2003 | 17 | 23 |
| 2004 | 11 | 38 |
| 2005 | 16 | 20 |
| 2006 | 12 | 16 |
| 2007 | 10 | 13 |
| 2008 | 12 | 17 |
| 2009 | 9 | 25 |
| 2010 | 12 | 21 |
| 2011 | 12 | 14 |
| 2012 | 13 | 9 |
| 2013 | 6 | 24 |
| 2014 | 15 | 25 |
| 2015 | 23 | 14 |
| 2016 | 20 | 35 |
| 2017 | 23 | 32 |
| 2018 | 15 | 15 |
| 2019 | 16 | 12 |
| 2020 | 5 | 5 |
| 2021 | 3 | 8 |
| 2022 | 7 | 10 |
| 2023 | 4 | 9 |
| 2024 | 6 | 7 |
| 2025 | 8 | 10 |
| 2026 | 4 | 13 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 335/16Having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered314
- C07C 335/06Having nitrogen atoms of thiourea groups bound to acyclic carbon atoms185
- C07C 335/24Containing any of the groups [image cpc-sch-c07c-0984.gif], x being a hetero atom139
- C07C 335/14Having nitrogen atoms of thiourea groups bound to carbon atoms of rings53
Recent patents
- Dihydrooxazole and thiourea derivatives modulating the NLRP3 inflammasome pathway12 May 2026US 12,624,010 B2AC Immune SA
- Cationic lipid compound, and preparation method therefor and use thereof10 Mar 2026US 12,569,449 B1Rongcan (Shanghai) Biotech Co., Ltd.
- Composition for tin-silver alloy electroplating comprising a complexing agent24 Feb 2026US 12,559,852 B2BASF SE
- Acyclic lipids and methods of use thereof10 Feb 2026US 12,545,636 B2ReNAgade Therapeutics Management Inc.
- Inhibitor of EIF2α dephosphorylation16 Dec 2025US 12,497,358 B2The Royal Institution for the Advancement of Learning/Mcgill University
- Lipid nanoparticle for targeted delivery of therapeutic payloads24 Sep 2026US 2026/0285801 A1Trustees of Tufts College
- Degradable cationic lipid containing a disulfide bond and applications thereof13 Aug 2026US 2026/0234104 A1Xiamen Sinopeg Biotech Co., Ltd.
- A strategy for the selective removal of mri contrast agents6 Aug 2026US 2026/0226079 A1Portland State University
- Masp-2 inhibitors and methods of use9 Jul 2026US 2026/0193179 A9Omeros Corporation
- Lipid compound and composition for delivery of active substance2 Jul 2026US 2026/0184669 A1Korea Research Institute of Bioscience and Biotechnology
Most cited
By later US patents
- Compounds and compositions for intracellular delivery of therapeutic agents143US 9,868,691 B2ModernaTX, Inc. · 2018
- Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding125US 5,326,856 ACytogen Corporation · 1994
- Thiol-modified hyaluronan121US 6,884,788 B2Anika Therapeutics, Inc. · 2005
- Ligands for metabotropic glutamate receptors and inhibitors of NAALADase119US 6,528,499 B1Georgetown University · 2003
- Chemical compounds as inhibitors of amyloid beta protein production110US 5,624,937 AEli Lilly and Company · 1997